The Cooper Companies, Inc. (COO)

89,75 +0,09 (+0,10%) Börsenschluss: 04:00PM EDT

The Cooper Companies, Inc.

6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
United States
925 460 3600
https://www.coopercos.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 15.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Albert G. White III	President, CEO & Non-Independent Director	2,91M	N/A	1970
Mr. Brian G. Andrews	Executive VP, CFO & Treasurer	1,22M	N/A	1979
Mr. Daniel G. McBride Esq.	Executive VP & COO	1,6M	N/A	1964
Ms. Holly R. Sheffield	President of CooperSurgical, Inc.	1,1M	N/A	1971
Mr. Gerard H. Warner III	President of CooperVision, Inc.	1M	N/A	1965
Mr. Agostino Ricupati	Senior VP & Chief Accounting Officer	670,71k	917,72k	1967
Mr. Kim Duncan	Vice President of Investor Relations & Risk Management	N/A	N/A	N/A
Mr. Nicholas S. Khadder	General Counsel & Corporate Secretary	N/A	N/A	1974

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Corporate Governance

The Cooper Companies, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 9, Vorstand: 6, Shareholderrechte: 2, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.